qRT-PCR analysis of bulk tumor RNA indicated that ACT+MS-275 treatment downregulated ARG1, NOS2, and TGFB1 expression, which may prohibit Treg expansion (Figure 5A). The gene discussed is NOS2; the disease is neoplasm.